Posted in | News | Business | Chemistry

Biobased Succinic Acid Producer Signs Exclusive Licensing Agreement with CELEXION

BioAmber, a renewable chemistry company, enters an exclusive technology licensing deal with CELEXION to produce adipic acid, as well as other chemical intermediates.

The renewable chemistry firm employs the same purification processes used for succinic acid to adipic acid production. The new agreement with CELEXION will support BioAmber to increase its infrastructure, expertise, customer base and collaborations. This in turn will speed up the production of renewable chemicals such as biobased adipic acid. The company has also set up a R&D facility in Plymouth, Minnesota for supporting its biobased adipic acid development program. The facility has been established with efficiencies in fermentation, analytical chemistry and molecular biology.

BioAmber’s CEO, Jean-Francois Huc says that the partnership with CELEXION is ideal for commercialization of biobased succinic acid. CELEXION's technology integrated with BioAmber’s novel purification process and capabilities lead to the development of renewable chemical, adipic acid. The current worth of adipic acid market is around $8 billion and the demand is nearly 3 million tons per year.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Chai, Cameron. (2019, February 09). Biobased Succinic Acid Producer Signs Exclusive Licensing Agreement with CELEXION. AZoM. Retrieved on November 22, 2024 from https://www.azom.com/news.aspx?newsID=28452.

  • MLA

    Chai, Cameron. "Biobased Succinic Acid Producer Signs Exclusive Licensing Agreement with CELEXION". AZoM. 22 November 2024. <https://www.azom.com/news.aspx?newsID=28452>.

  • Chicago

    Chai, Cameron. "Biobased Succinic Acid Producer Signs Exclusive Licensing Agreement with CELEXION". AZoM. https://www.azom.com/news.aspx?newsID=28452. (accessed November 22, 2024).

  • Harvard

    Chai, Cameron. 2019. Biobased Succinic Acid Producer Signs Exclusive Licensing Agreement with CELEXION. AZoM, viewed 22 November 2024, https://www.azom.com/news.aspx?newsID=28452.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.